SGMT Sagimet Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SGMT

Price (delayed)

$10.42

Market cap

$647.69M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.29

Enterprise value

$483.74M

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 94
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 12
Highlights
The quick ratio has surged by 156% year-on-year and by 124% since the previous quarter
The equity has soared by 150% since the previous quarter and by 97% year-on-year
The net income is up by 21% year-on-year but it has declined by 8% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://sagimet.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of SGMT

SGMT stock price

How has the Sagimet Biosciences stock price performed over time
Intraday
-6.04%
1 week
-0.38%
1 month
1.66%
1 year
54.83%
YTD
76.01%
QTD
34.8%

Financial performance

How have Sagimet Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$52.63M
Net income
-$47.08M
Gross margin
N/A
Net margin
N/A
SGMT's operating income is up by 21% YoY but it is down by 8% QoQ
The net income is up by 21% year-on-year but it has declined by 8% since the previous quarter

Price vs fundamentals

How does SGMT's price correlate with its fundamentals

Growth

What is Sagimet Biosciences's growth rate over time

Valuation

What is Sagimet Biosciences stock price valuation
P/E
N/A
P/B
2.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has increased by 30% YoY and by 4.4% from the previous quarter
The equity has soared by 150% since the previous quarter and by 97% year-on-year
SGMT's price to book (P/B) is 48% higher than its last 4 quarters average of 1.8

Efficiency

How efficient is Sagimet Biosciences business performance
Sagimet Biosciences's return on assets has increased by 20% YoY and by 14% QoQ
The company's return on equity rose by 20% YoY and by 15% QoQ
The return on invested capital rose by 18% year-on-year but it has declined by 6% since the previous quarter

Dividends

What is SGMT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SGMT.

Financial health

How did Sagimet Biosciences financials performed over time
Sagimet Biosciences's current ratio has surged by 157% YoY and by 121% QoQ
The quick ratio has surged by 156% year-on-year and by 124% since the previous quarter
The debt is 99% less than the equity
The equity has soared by 150% since the previous quarter and by 97% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.